Cooper Companies | COO - Прибыль до налогообложения

Биржевая цена
61.44
Изменение за день
0.50 0.82%
Ежемесячно
-11.55%
Ежегодный
-24.61%
Q2 прогноз
58.41




Прибыль до налогообложения Изменить Дата
Abbott USD 2.39B 27M 2026-03
Align Technology USD 148.89M 27.71M 2026-03
AtriCure USD 394K 1.97M 2026-03
Avanos Medical USD 1.2M 2.4M 2025-12
Bausch Health Companies USD 56M 162M 2025-12
Baxter International USD -756M 877M 2025-12
Bayer EUR -3.37B 2.21B 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dentsply International USD -42M 105M 2026-03
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 169.23M 25.24M 2025-12
Haemonetics USD 59.97M 8.69M 2025-12
Inogen USD -6.06M 467K 2024-09
Insulet USD 113M 27.2M 2026-03
Integra LifeSciences USD -2.41M 6.72M 2026-03
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Novartis USD 5.17B 637M 2025-09
ResMed USD 496.15M 13.77M 2025-12
STAAR Surgical USD -20.65M 39.44M 2025-12
Steris USD 257.8M 66.6M 2025-12
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD 4.68M 29.82M 2025-12
Teleflex USD 218.94M 657.52M 2025-12
Utah Medical Products 418K 3K 2024-09
Zimmer Biomet Holdings USD 98M 320.7M 2025-12